Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Rapid correction of low vitamin D status in nursing home residents 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment
Top Ten Searches
rheumatoid arthritis lupus polymyalgia sjogrens fibromyalgia amyloidosis vasculitis urate raynauds myositisYour Article Summary
MHC class I and II expression in juvenile dermatomyositis skeletal muscle
Clinical and Experimental Rheumatology Online, 07/30/09
Sallum AME et al. – Study suggest that MHC I expression in muscle fibres is a premature and late marker of juvenile dermatomyositis (JDM) patient independent to corticotherapy; MHC II expression was lower in JDM than in polymyositis (PM) and dermatomyositis (DM).
Methods- Aim was to assess MHC I and II expressions in muscle fibres of JDM and compare with the expression in PM, DM and dystrophy
- 48 JDM pts and 17 controls (8 PM, 5 DM and 4 dystrophy)
- Mean age at disease onset was 7.1±3.0 yrs and the mean duration of weakness before biopsy was 9.4±12.9 mo
- Routine histochemistry and IHC for MHC I and II were performed on serial frozen muscle sections in all pts
- MHC I expression was positive in 47 (97.9%) JDM cases
- This expression was independent of:
- Time of disease
- Corticotherapy previous to muscle biopsy, and
- Grading of inflammation observed in clinical, laboratorial and histological parameters
- Expression of MHC I was similar on JDM, PM and DM, and lower in dystrophy
- On the other hand, MHC II expression was positive in just 28.2% of JDM cases
- It was correlated to histological features as inflammatory infiltrate, increased connective tissue and VAS for global degree of abnormality
- MHC II expression was similar in DM/PM and lower in JDM and dystrophy
- It was based on the frequency of positive staining rather than to the degree of the MCH II expression
Related Articles
Distinct Conformations of Ly49 Natural Killer Cell Receptors Mediate MHC Class I Recognition in Trans and Cis
Immunity, 10/28/09
Relevance Score: 44%
Distinct MHC gene expression patterns during progression of melanoma
Genes, Chromosomes and Cancer, 11/02/09
Relevance Score: 43%
Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II
Immunology, 10/13/09
Relevance Score: 43%
Skeletal muscle cell MHC I expression: Implications for statin-induced myopathy
Muscle & Nerve, 10/12/09
Relevance Score: 43%
Design of Agonistic Altered Peptides for the Robust Induction of CTL Directed towards H-2Db in Complex with the Melanoma-Associated Epitope gp100
Cancer Research, 10/06/09
Relevance Score: 43%
Today in Pediatric Rheumatology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new graph and scoring system simplified analysis of changing states: disease remissions in a rheumatoid arthritis clinical trial
Journal of Clinical Epidemiology, 12/11/09
Association of juvenile idiopathic arhrtitis and functional constipation
International Journal of Clinical Rheumatology, 12/04/09
Plasma level of myeloperoxidase in children with juvenile idiopathic arthritis (a pilot study)
Central European Journal of Medicine, 11/25/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


